
Sign up to save your podcasts
Or
Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.
4.4
3030 ratings
Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.
17 Listeners
14 Listeners
65 Listeners
11 Listeners
72 Listeners
0 Listeners
6 Listeners
325 Listeners
38 Listeners
113 Listeners
58 Listeners
122 Listeners
43 Listeners
27 Listeners
56 Listeners
88 Listeners
169 Listeners